Association between baseline total serum IgE and chronic spontaneous urticaria relapse after omalizumab discontinuation
Published: 4 June 2026| Version 1 | DOI: 10.17632/dvmf7tn4b8.1
Contributors:
, Description
Supplementary methods, figures, and tables
Files
Steps to reproduce
The study protocol was registered at PROSPERO (identifier: CRD420261288927).
Categories
Immunoglobulin E, Biologic Agent, Meta-Analysis, Urticaria